Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Mixed Results at Major Gold Companies

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day for Streetwise Reports   08/07/2018

Fund manager Adrian Day takes a look at several major gold companies in his portfolio.

Wheaton Precious Metals Corp. (WPM:TSX; WPM:NYSE, US$21.18) continues to diversify away from silver with two new streams, a gold and palladium stream on the Stillwater Mine (a long-life mine in the U.S.) and a cobalt stream on Voisey’s Bay nickel mine. Both streams are front-loaded; Wheaton will receive 4.5% of the palladium reducing on hurdles to 2.25% and 42% of the cobalt (expected to commence in 2021 after a mine expansion) down to 21% over time. The first has a 6.1% IRR, and second 11% (before tax), reasonably high in the current streaming environment.

However, Wheaton, already with a less than sterling balance sheet, funded both—$500 million and $390 million respectively—from its credit facility, adding to its debt.

Wheaton is undervalued relative to the other large royalty and streaming companies. The ongoing dispute with Canadian tax authorities is largely priced in, though a completely unfavorable outcome would hurt the stock, particularly given that the amount in dispute has not been reserved. We are holding Wheaton.

Not achieving goals yet

Goldcorp Inc. (G:TSX; GG:NYSE, US$12.34) saw a weak quarter, with lower gold production and higher-than-estimated costs. The company has advised the third quarter will also be soft, while forecasting a strong fourth quarter. The company’s grand 20/20/20 goal (for 20% higher production, higher reserves, and lower costs) was restated, but the company does not appear to be making great strides towards the goals. Execution is the key. Two major new mines have been experiencing more difficult ramp-up periods than expected—that’s Cerro Negro and Éléonore—though both are improving, and these two mines give the company potential to go some way towards their production and cost goals.

The balance sheet, with $2.4 billion of net debt, is not as strong as many of its peers, though its valuation is below its peers. We are holding, but not energetically buying more. However, the current price—down over two dollars from mid-June—is overdone, and probably a good price for a trade here.

Good quarters at Yamana and Osisko

Yamana Gold Inc. (YRI:TSX; AUY:NYSE; YAU:LSE, US$3.10) had a good quarter, with better-than-expected production and lower costs. A new mine, Cerro Moro, just announced commercial production so will contribute in the second-half, which should be another good period for Yamana.

Net debt is a reasonable $1.58 billion, with liquidity of almost $900 million (most of which is a credit facility, not cash). It is valued below peers. We are holding for the time being, but given that Yamana has disappointed us time and time again, we are not buying.

Stock slammed by mine delay

Osisko Gold Royalties Ltd. (OR:TSX; OR:NYSE, US$9.16) reported good results, particularly a record production quarter at Canadian Malartic, its cornerstone asset. The bad news was the announcement of a blockade at Lydian’s Amulsar project in Armenia, which pushes back production to the middle of next year (at the earliest). This was to have been Osisko’s next major cash-flowing asset, and the news drove Osisko’s share price down sharply ahead of its own results.

The balance sheet remains strong. Though cash is down to $189 million, after new investments of $108 million in the quarter (and two of which carry future payment commitments), debt is also down after a $52 million repayment to $450 million. Osisko also has a large portfolio of junior companies valued around $450 million, and it is expected that Pretium will buy back its royalty, giving Osisko US$119 million before year end, so the balance sheet remains, and will remain, strong.

Osisko trades at a meaningful discount on several metrics to other large royalty companies, only partly justified (smaller, and higher-risk in exploration), also now at a discount to NAV. Take advantage of the sharp price decline—from $9.68 at the end of July; Osisko is a strong buy here.

Adrian Day, London-born and a graduate of the London School of Economics, heads the money management firm Adrian Day Asset Management, where he manages discretionary accounts in both global and resource areas. Day is also sub-adviser to the EuroPacific Gold Fund (EPGFX). His latest book is “Investing in Resources: How to Profit from the Outsized Potential and Avoid the Risks.”

Read what other experts are saying about:

[NLINSERT]

Disclosure:
1) Adrian Day: I, or members of my immediate household or family, own shares of the following companies mentioned in this article: Osisko Gold Royalties. I personally am, or members of my immediate household or family are, paid by the following companies mentioned in this article: None. My company has a financial relationship with the following companies mentioned in this article: None. Funds controlled by Adrian Day Asset Management hold shares of the following companies mentioned in this article: Wheaton Precious Metals, Goldcorp, Yamana Gold and Osisko Gold Royalties. I determined which companies would be included in this article based on my research and understanding of the sector.
2) The following companies mentioned in this article are billboard sponsors of Streetwise Reports: Wheaton Precious Metals. Click here for important disclosures about sponsor fees. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security.
3) Statements and opinions expressed are the opinions of the author and not of Streetwise Reports or its officers. The author is wholly responsible for the validity of the statements. The author was not paid by Streetwise Reports for this article. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
4) This article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. This article is not a solicitation for investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company mentioned on Streetwise Reports.
5) From time to time, Streetwise Reports and its directors, officers, employees or members of their families, as well as persons interviewed for articles and interviews on the site, may have a long or short position in securities mentioned. Directors, officers, employees or members of their immediate families are prohibited from making purchases and/or sales of those securities in the open market or otherwise from the time of the interview or the decision to write an article, until one week after the publication of the interview or article. As of the date of this article, officers and/or employees of Streetwise Reports (including members of their household) own securities of Wheaton Precious Metals, Osisko Gold Royalties and Pretium Resources, companies mentioned in this article.

( Companies Mentioned: G:TSX; GG:NYSE, OR:TSX; OR:NYSE, WPM:TSX; WPM:NYSE, YRI:TSX; AUY:NYSE; YAU:LSE, )


Source: https://www.streetwisereports.com/article/2018/08/07/mixed-results-at-major-gold-companies.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login